NewsStackNewsStack
Daily Brief: Which companies are hyping vs delivering: red flags, real signals and repeat offenders, free daily.

TELY

TSX:TELYTSX
11 announcements
Credibility Score61%
TelyRx Announces Third Quarter 2026 Financial Results
OverhypedModerate hypedeteriorating

Revenue doubled, but losses and cash burn accelerated despite recurring customer growth.

5 Nov 2026, 21:45 UTC
▼
TelyRx Expands Women's Health Offerings with New Menopause Supplement
OverhypedModerate hypeunclear

TelyRx adds SISTERLY’s menopause supplement, expanding its U.S. women’s health platform.

7 Oct 2026, 11:30 UTC
▼
TelyRx Launches New Brand and Digital Experience Inspired by Patient Feedback
OverhypedModerate hypeunclear

TelyRx expands its digital pharmacy, but omits all financial performance details.

4 Aug 2026, 12:00 UTC
▼
TelyRx Expands Operations in Clearwater, Fla., Tripling Footprint to Meet Growing Demand for Digital Healthcare
OverhypedModerate hypeimproving

Rapid growth, but profitability and sustainability remain unproven and undisclosed.

14 Jul 2026, 11:16 UTC
▼
TelyRx Surpasses 1 Million Prescriptions, Underscoring Growing Demand for Digital Pharmacy
OverhypedModerate hypeunclear

TelyRx hits a milestone, but offers little substance beyond headline prescription numbers.

8 Jun 2026, 12:08 UTC
▼
TelyRx Announces First Quarter 2026 Financial Results
OverhypedModerate hypeimproving

Strong revenue growth, but losses are widening and operational proof is still thin.

12 May 2026, 22:05 UTC
▼
TelyRx Announces Year-End 2025 Financial Results
Routineunclear

This is a bare-bones regulatory filing, not an investable signal or performance update.

21 Apr 2026, 20:51 UTC
▼